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INTRODUCTION
Neural cell adhesion molecule (NCAM), a glycoprotein which is widely expressed in the brain, comprises an extracellular region with 5 N terminal Ig and 2 fibronectin-type III (F3 modules). NCAM interacts with growth factor receptors including fibroblast growth factor receptor (FGFR) and the FGFR-1 binding site of NCAM is now known to be a small peptide loop in the F3 region (Kiselyov et al., 2003) . The 15 amino acid peptide, FGL peptide, which encompasses the FGFR-1 binding site of NCAM, exerts a plethora of effects. It enhances hippocampal function (Cambon et al., 2004 , Dallerac et al., 2011 and plays a role in neuronal development (Cambon et al., 2004 , Li et al., 2009 , Dallerac et al., 2011 . FGL has also been shown to be protective against 6-hydroxydopamine and amyloid-β (Aβ) in vitro (Neiiendam et al., 2004) and decreases neuronal damage in hippocampal organotypic slice cultures subjected to oxygen-glucose (Skibo et al., 2005) . Protective effects of FGL in vivo have also been reported; thus it has been shown to attenuate the increased Aβ-immunoreactivity and deficit in cognitive function induced by intracerebroventricular administration of pre-aggregated Aβ [25] [26] [27] [28] [29] [30] [31] [32] [33] [34] [35] (Klementiev et al., 2007) .
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More recently, an anti-inflammatory effect of FGL has been observed; the evidence indicated that FGL restored the age-related imbalance in hippocampal concentrations of IGF-1 and IFNγ and consequently attenuated the glial cell activation associated with aging , Ojo et al., 2011 . Administration of FGL to aged rats for 3 weeks was shown to attenuate the age-related deficit in LTP and the increase in microglial activation (Downer et al., 2010) ; this was coupled with an FGL-induced increase in CD200 on neurons (Downer et al., 2010) , particularly boutons (Ojo et al., 2012) , and also on astrocytes (Ojo et al., 2012) . CD200, which is expressed on neurons and endothelial cells, by interacting with its cognate receptor, CD200R which is expressed on microglia but not other cells in the brain, plays an important role in maintaining the resting non-inflammatory state. Thus microglia of CD200-deficient mice spontaneously exhibit many features of activation, including a less ramified morphology and increased expression of markers like CD11b and CD45 and increased inflammatory changes associated with experimentally-induced autoimmune diseases like experimental autoimmune encephalomyelitis and uveitis (Hoek et al., 2000 , Copland et al., 2007 . Recent data have indicated that glia prepared from CD200-deficient mice responded more profoundly to lipopolysaccharide (LPS) than cells from wildtype mice (Costello et al., 2011) ; these cells exhibited increased expression of markers of microglial activation and increased production of inflammatory cytokines, interleukin (IL)-1β, IL-6 and tumour necrosis factor-α (TNFα).
Our previous findings indicated that the FGL-induced decrease in microglial activation was associated with increased CD200 expression; in this study, we set out to evaluate whether the effects of FGL were CD200-dependent. We demonstrate that pretreatment of cultured glia with FGL attenuated the LPS-induced increase in markers of microglial activation and proinflammatory production in cells prepared from wildtype mice, but exerted 5 no effect on the LPS-induced changes in CD200-/-mice. The data indicate that the ability of FGL to modulate microglial activation is dependent on CD200.
EXPERIMENTAL PROCEDURES

Preparation of cultured cortical rat mixed glia
Mixed glial cells, isolated astrocytes and isolated microglia were prepared from neonatal wildtype or CD200
-/-mice as described previously (Costello et al., 2011) . In some experiments, mixed glia were pretreated with FGL (10μg/ml) for 24 hours before being incubated in the presence or absence of LPS (1μg/ml) for a further 24 hours. This regime was chosen following preliminary experiments which showed that pretreatment induced significantly greater effects than co-treatment at 10μg/ml FGL. We examined the effects of LPS after 24 hours since, in a previous study, we observed that the changes in cytokines were maximal at this time (Minogue et al., 2012) . In some experiments, purified astrocytes were incubated in the presence or absence of FGL (10μg/ml) for 24 hours to assess its effect on CD200 protein expression.
In a separate series of experiments, cell membranes were isolated from cultured astrocytes prepared from C57BL/6 mice using a subcellular protein fractionation kit (Thermo Scientific, US). Confluent astrocytes were incubated in trypsin-EDTA (1ml, 15 min, 37ºC), the cell suspension was centrifuged (500 x g, 5 min), the pellet was washed and cells were resuspended in phosphate-buffered saline (PBS, 1ml). Samples were centrifuged (500 x g, 3 min), the pellet was re-suspended in ice-cold Cytoplasmic Extraction Buffer (100μl, Thermo Scientific, US), incubated (4ºC, 10 min) and centrifuged (3,000 x g, 5 min). The pellet was resuspended in ice-cold Membrane Extraction Buffer (100μl, Thermo Scientific, US), incubated (4ºC, for 10 min) and centrifuged (3,000 x g, 5 min) to provide a supernatant which contained the membrane extract. 6 absence of this membrane extract (20ng/ml) for 2 hours prior to the addition of LPS (1μg/ml) and incubation continued for 24 hours.
Quantitative real time PCR
RNA was isolated from cultures using the Nucleospin® RNAII KIT (Macherey-Nagel, Duren, Germany) and cDNA was prepared using High-Capacity cDNA RT kit according to the manufacturer's instructions (Applied Biosystems, UK). Real-time PCR for the detection of CD40, ICAM-1, CD11b, IL-1β, IL-6 and TNFα mRNA was performed with predesigned Taqman gene expression assays (Applied Biosystems, UK). The assay IDs were as follows:
Mm00434228_m1, IL-6 Mm00446190_m1 and TNFα Mm00443258_m1. Samples were assayed on an Applied Biosystems 7500 Fast Real-Time PCR machine and gene expression was calculated relative to the endogenous control samples (β-actin) to give a relative quantification (RQ) value (2 -DDCT , where CT is threshold cycle).
Analysis of cytokine expression by ELISA
The concentrations of IL-1β and IL-6 were assessed by ELISA in supernatant from primary rat mixed glial cultures as previously described (Minogue et al., 2012) . Briefly, 96-well plates (Nunc-Immuno plate with Maxisorp surface, Denmark) were coated with capture antibody (rat anti-mouse IL-1β (4μg/ml in PBS;; R & D Systems, US), rat anti-mouse IL-6 (2μg/ml in PBS; BD Biosciences, UK), or goat anti-mouse TNFα antibody (0.8 μg/ml in PBS BD Biosciences, UK)) and incubated (overnight, 4ºC). Triplicate samples or standards (50µl) were added and plates were incubated (2 hours, room temperature) and washed before addition of detection antibody (600ng/ml in 2% goat serum for IL-1β or 200ng/ml in PBS containing 10% FBS for IL-6 and TNFα). Samples were incubated (2 hours, room 3  4  5  6  7  8  9  10  11  12  13  14  15  16  17  18  19  20  21  22  23  24  25  26  27  28  29  30  31  32  33  34  35  36  37  38  39  40  41  42  43  44  45  46  47  48  49  50  51  52  53  54  55  56  57  58  59  60  61  62  63  64  65 7 temperature), washed, incubated with streptavidin-horseradish peroxidase conjugate (100µl; 1:200; 20 min, room temperature) and washed before addition of substrate solution (100µl; 1:1 H 2 O 2 :tetramethylbenzidine; R&D Systems, US). After colour development, the reaction was stopped by adding 50µl 1M H 2 SO 4 and plates were read at 450nm (Labsystem Multiskan RC, UK).
Statistical Analysis
Data are expressed as means ± standard error of mean (SEM). Analysis of variance (ANOVA) was performed to determine whether significant differences existed between conditions. If this indicated significance (p<0.05), the appropriate a post-hoc test was used to determine which conditions significantly differ from each other. Two-tailed unpaired Students t-tests were also performed, where indicated, to compare treatment groups; significance was set as p<0.05.
RESULTS
LPS induced a significant increase in mRNA expression of CD40, ICAM-1 and CD11b in mixed glia prepared from wildtype and CD200 -/-mice ( These data obtained in mixed glia indicate that the loss of CD200 markedly affects expression of markers of microglial activation; this is probably because astrocytes, which express CD200 (Costello et al., 2011) , modulate LPS-induced changes in microglia. To confirm the presence of CD200 on astrocytes, we show that CD200 is expressed on CD11b -cells in a mixed glial cell preparation and that expression was not detectable in cells prepared from CD200 -/-mice ( Figure 4A ). The data also show that expression of CD200 on purified astrocytes was significantly upregulated in astrocytes exposed to FGL ( * p<0.05;; Student's ttest for independent means; Figure 4B ) which concurs with the evidence that FGL also increased expression on neurons ).
Having confirmed CD200 expression on astrocytes we prepared purified microglia and pre-incubated them in the presence or absence of astrocytic membranes for 2 hours prior to the addition of LPS. LPS significantly increased IL-1β mRNA in microglia ( *** p<0.001;
ANOVA; F (4,17) =16.01; Figure 6A ) but pre-incubation with the membrane preparation 3 4  5  6  7  8  9  10  11  12  13  14  15  16  17  18  19  20  21  22  23  24  25  26  27  28  29  30  31  32  33  34  35  36  37  38  39  40  41  42  43  44  45  46  47  48  49  50  51  52  53  54  55  56  57  58  59  60  61  62  63  64 Figure 6 ) and these changes were attenuated when cells were pre-incubated with the astrocytic membrane preparation ( + p<0.05; ++ p<0.01; +++ p<0.001; ANOVA; Figure 6 ; LPS alone versus LPS+astrocytic membrane).
DISCUSSION
The central finding in this study is that FGL exerts its modulatory effects on LPS-induced activation in a CD200-dependent manner and that its expression on astrocytes is pivotal to this action.
We set out to compare the effects of LPS on mixed glial cultures prepared from CD200
-/-, compared with glia from wildtype, mice and, specifically, to assess whether the predicted FGL-associated modulatory effect was CD200-dependent. The data indicate that LPS increased mRNA expression of markers of microglial activation and inflammatory cytokine production in glia prepared from wildtype mice, but that this effect was significantly greater in glia prepared from CD200 -/-mice. Importantly, whereas pre-treatment of glia with FGL significantly attenuated the LPS-induced changes in cells from wildtype mice, it exerted no effect on cells from CD200 -/-mice indicating that its effect was CD200-dependent.
Moreover, when LPS-treated microglia were incubated in the presence of a membrane preparation obtained from astrocytes, the induced increases in inflammatory cytokine production were completely blocked. This indicates that astrocytes play an important role in modulating microglial activation. 3  4  5  6  7  8  9  10  11  12  13  14  15  16  17  18  19  20  21  22  23  24  25  26  27  28  29  30  31  32  33  34  35  36  37  38  39  40  41  42  43  44  45  46  47  48  49  50  51  52  53  54  55  56  57  58  59  60  61  62  63  64  65 10 LPS is a potent activator of microglia and previous work from this laboratory has demonstrated its ability to stimulate transcription and release of inflammatory mediators in mixed glial cultures (Lyons et al., 2009 , Watson et al., 2010 , Costello et al., 2011 . The present data reiterate these effects showing LPS-induced increases in mRNA expression of CD40, ICAM-1 and CD11b, as well as mRNA expression and release of IL-1β, TNFα and IL-6. Pre-incubation of cells in the presence of FGL completely blocked these LPS-induced changes. The ability of FGL to inhibit LPS-induced IL-1β production in mixed glia, and also microglia, has been reported and the earlier evidence indicated that this was IL-4-dependent (Downer et al., 2010) . FGL also attenuates the IFNγ-induced increase in microglial activation, specifically expression of MHCII and CD40 mRNA; in this case the evidence suggested that FGL acted in an IGF-1-dependent manner ).
Significantly, IL-4 and IGF-1 both increased expression of CD200, suggesting that the effect of FGL was linked with increased CD200.
Here, we demonstrate that LPS induced a significantly greater effect on all parameters in glia prepared from CD200 -/-, compared with wildtype, mice. The LPS-induced increase in cytokine release from cells has previously been shown to be enhanced in the absence of CD200 (Costello et al., 2011) but the current data extend this to show a parallel upregulation in cytokine mRNA and to show that the LPS-induced increase in mRNA expression of CD40, ICAM-1 and CD11b, which indicate microglial activation, was greater in CD200 -/-mice.
Even under resting conditions, CD11b mRNA, although not ICAM-1 or CD40, was increased in glia prepared from CD200 -/-, compared with wildtype, mice, which might affect macrophage/microglial cell migration or cell-cell adhesion (Solovjov et al., 2005) .
Interestingly, retinal macrophage infiltrates have been observed in CD200-deficient mice with EAU (Broderick et al., 2002) and we have recently observed increased macrophage infiltration into the brain of these animals (Denieffe et al., unpublished) . Whereas an increase 11 in mRNA expression is not always paralleled by an increase in protein, we have previously reported that increased CD40 mRNA and CD11b mRNA expression in mixed glia prepared from CD200-deficient, compared with wildtype, mice was paralleled by increased staining when analysed by flow cytometry (Costello et al., 2011) . This suggests that, at least in the case of these markers, a close correlation between mRNA expression and cell surface expression of the protein was observed.
We have attributed the increased responsiveness to LPS in CD200 -/-mice to an increase in expression of TLR4 (Costello et al., 2011) . Interestingly, cells prepared from CD200 -/-mice are also more responsive to the TLR2 agonist Pam 3 CSK 4 and this may be explained by the observed increased expression of TLR2 on cells prepared from CD200 -/-mice, even under resting conditions (Costello et al., 2011) . This enhanced reactivity of immune cells from CD200 -/-mice to an inflammatory challenge in vitro corroborates reports by other groups that investigated inflammatory insults in vivo. Studies examining the susceptibility of CD200 -/-mice to experimentally-induced allergic disease or viral infection revealed increased responsiveness to these inflammatory stimuli (Campbell et al., 2000 , Hoek et al., 2000 , Snelgrove et al., 2008 . Additionally the onset of EAE was dramatically accelerated in CD200 -/-mice, and the increase in iNOS-and CD68-positive macrophages appeared earlier and persisted for longer in the spinal cord of these mice (Hoek et al., 2000) . Disease kinetics of EAU in CD200 -/-mice displayed a similar course to that of EAE, with an earlier onset and increased severity of symptoms (Copland et al., 2007) and the inflammatory response following facial nerve transaction was also enhanced in these animals (Hoek et al., 2000) .
Consistent with the importance of CD200 in moderating microglial activation and inflammatory changes, we have recently reported that CD200Fc attenuates the age-related and LPS-induced increase in microglial activation and, concurrently, partially overcomes the deficits in LTP observed in aged rats and LPS-treated rats (Cox et al., 2012) . Interestingly 12 CD200 expression is decreased in several brain areas in post-mortem tissue obtained from patients with Alzheimer's disease (Walker et al., 2009) . Although receptor expression is unchanged, induction of CD200R expression is impaired in monocyte-derived macrophage obtained from PD patients (Luo et al.) and it has been proposed that this may reflect the situation in microglia and therefore partially explain the increased microglial activation associated with the disease (Wang et al., 2007) . These findings, as well as those from preclinical studies suggest that CD200R may be a useful target for therapeutics in neuroinflammatory conditions.
Work from this laboratory has revealed the expression of CD200 on neurons in vitro and identified that the immunomodulatory effect of neurons on glial cells in culture was CD200-dependent (Lyons et al., 2007) . This proclivity is shared by endothelial cells (Miller et al., 2011) and, interestingly, both neurons and endothelial cells attenuated the effect of LPS in cultured glia. The current study demonstrated the presence of CD200 on CD11b-negative cells indicating that CD200 is expressed on astrocytes as previously described (Costello et al., 2011 , Ojo et al., 2012 and show that addition of an astroglial membrane preparation to microglial cultures attenuates the LPS-induced increases in cytokine production.
Significantly incubating astrocytes in the presence of FGL enhanced expression of CD200 and therefore FGL may exert its anti-inflammatory action in vivo by enhancing astrocytic, as well as neuronal CD200, expression (Downer et al., 2010) .
It has been suggested previously that astrocytes can modulate microglial activity by enhancing or dampening their activation state through release of pro-or anti-inflammatory cytokines (Eng et al., 2000) ; the present data provide another mechanism by which control can be exerted suggesting that, in addition to soluble factors, astrocytes can modulate microglial activity by cell:cell contact, involving CD200-CD200R interaction. 8  9  10  11  12  13  14  15  16  17  18  19  20  21  22  23  24  25  26  27  28  29  30  31  32  33  34  35  36  37  38  39  40  41  42  43  44  45  46  47  48  49  50  51  52  53  54  55  56  57  58  59  60  61  62  63  64  65 
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